AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 152 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $1,069,000 | +31.3% | 79,106 | +14.4% | 0.00% | 0.0% |
Q3 2020 | $814,000 | +311.1% | 69,128 | +414.2% | 0.00% | +200.0% |
Q2 2020 | $198,000 | +7.0% | 13,444 | -1.6% | 0.00% | 0.0% |
Q1 2020 | $185,000 | -53.5% | 13,665 | -16.9% | 0.00% | 0.0% |
Q4 2019 | $398,000 | +56.1% | 16,435 | +23.9% | 0.00% | 0.0% |
Q3 2019 | $255,000 | +10.9% | 13,269 | +70.7% | 0.00% | 0.0% |
Q2 2019 | $230,000 | -46.4% | 7,773 | -13.9% | 0.00% | -50.0% |
Q1 2019 | $429,000 | +73.7% | 9,030 | +31.9% | 0.00% | +100.0% |
Q4 2018 | $247,000 | -23.5% | 6,846 | +30.3% | 0.00% | 0.0% |
Q3 2018 | $323,000 | -9.3% | 5,255 | -0.3% | 0.00% | -50.0% |
Q2 2018 | $356,000 | +16.3% | 5,273 | -6.5% | 0.00% | 0.0% |
Q1 2018 | $306,000 | -10.5% | 5,642 | -1.4% | 0.00% | 0.0% |
Q4 2017 | $342,000 | +35.2% | 5,721 | +9.7% | 0.00% | +100.0% |
Q3 2017 | $253,000 | -2.3% | 5,217 | +6.2% | 0.00% | -50.0% |
Q2 2017 | $259,000 | +21.6% | 4,914 | +4.7% | 0.00% | +100.0% |
Q1 2017 | $213,000 | – | 4,695 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|